Men with IGF-I levels >113 ng ml−1 were 59% less likely to develop kidney cancer than men with IGF-I levels ⩽113 ng ml−1 (OR=0.41; 95% CI=0.23–0.75). Here, IGF1 is linked to kidney cancer.